ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1954

Examination of Rehabilitation Referrals from Rheumatology Practices for Adults with Rheumatoid Arthritis in the RISE Registry: A Feasibility and Descriptive Study

Louise Thoma1, Jing Li2 and Gabriela Schmajuk3, 1University of North Carolina, Chapel Hill, NC, 2University of California, San Francisco, San Francisco, CA, 3UCSF / SFVA, San Francisco, CA

Meeting: ACR Convergence 2024

Keywords: Administrative Data, Occupational therapy, physical therapy, Rehabilitation, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Health Services Research – ACR/ARP Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Adults with rheumatoid arthritis (RA) commonly report functional limitations, pain, and fatigue that contribute to diminished quality of life and limit participation in valued life activities. Rehabilitation services, including physical therapy (PT) and occupational therapy (OT), are specifically indicated to improve physical function and optimize participation in life activities, yet rehabilitation utilization in the United States lags behind the expected need. The extent to which rheumatology clinicians refer adults with RA to rehabilitation services is unknown. We assessed referrals to rehabilitation (PT or OT) services across rheumatology practices within the ACR’s RISE registry.

Methods: Data were derived from RISE, a national, EHR-enabled registry that passively collects data on all patients seen by participating rheumatology practices. As of September 2023, RISE held validated data from 1333 providers in 242 practices, representing approximately 30% of the U.S. clinical rheumatology workforce. Practices were eligible for this study if they had ≥ 1 patient record indicating a referral to rehabilitation in the “plan of care” for any patient, indicating that such referrals would be captured in the data tables available through the RISE registry. We included patients from eligible practices who were ≥ 18 years old, had ≥ 2 ICD codes for RA (714.x, M05.x, M06.x but not M06.4) ≥ 30 days apart, and had ≥ 1 visit in 2022. The primary outcome was the percentage of patients with ≥ 1 rehabilitation (PT or OT) referral documented in 2022. We also expanded the window to assess the percentage of patients who had ≥ 1 rehabilitation referral at any time by the end of 2022. The percentage of patients with ≥1 rehabilitation referral was reported by patient characteristics, including age, gender, self-reported race and ethnicity, and insurance. We also examined variations in documentation of rehabilitation referral at the practice level among practices with ≥ 20 patients.

Results: Of 240 practices with any “plan of care” data available in the RISE registry, 215 (90%) practices had ≥ 1 patient record for which rehabilitation was mentioned. 198,517 adult patients with RA from 206 practices were included, with a mean (SD) age of 63 (14) years. 77% were female, 67% non-Hispanic white, and the most had either Medicare (40%) or private (38%) insurance. Only 2.7% of patients had ≥1 rehabilitation referral in 2022; 9.2% had ≥1 referral in the expanded “ever” window. The percentage of patients with a rehabilitation referral in 2022 ranged from 1-4% across demographic groups (Table). Across the 197 practices with ≥ 20 adult patients with RA, we observed wide variation in rehabilitation referrals (Range 0% – 19.3%; Figure).

Conclusion: Extracting rehabilitation referrals from the plan of care field in the RISE registry was feasible, as eligible data were available for 90% of participating practices. Preliminary estimates indicate that rehabilitation referral from rheumatology practices is low, though there is considerable variation across practices. This study should be repeated in other data sources, given the limitation of data available in the RISE registry and the challenges of extracting information on rehabilitation referrals.

Supporting image 1

Percentage of patients with at least one rehabilitation referral in 2022 and ever across demographic characteristic and insurance groups

Supporting image 2

Percentage of patients with at least one rehabilitation referral in 2022 across eligible RISE practices (> 20 patients with RA), ranked in ascending order


Disclosures: L. Thoma: None; J. Li: None; G. Schmajuk: None.

To cite this abstract in AMA style:

Thoma L, Li J, Schmajuk G. Examination of Rehabilitation Referrals from Rheumatology Practices for Adults with Rheumatoid Arthritis in the RISE Registry: A Feasibility and Descriptive Study [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/examination-of-rehabilitation-referrals-from-rheumatology-practices-for-adults-with-rheumatoid-arthritis-in-the-rise-registry-a-feasibility-and-descriptive-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/examination-of-rehabilitation-referrals-from-rheumatology-practices-for-adults-with-rheumatoid-arthritis-in-the-rise-registry-a-feasibility-and-descriptive-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology